Adenosine A3 Receptor Protein is involved in circadian rhythm regulation and has been implicated in neurodegenerative diseases. This page provides information about its structure, function, and role in neurodegeneration.
Adenosine A3 Receptor Protein plays a critical role in the molecular circadian clock and its dysregulation may contribute to neurodegeneration.
| Adenosine A3 Receptor Protein | |
|---|---|
| Protein Name | Adenosine A3 Receptor Protein |
| Gene | ADORA3 |
| UniProt ID | P0DP24 |
| Molecular Weight | 36 kDa |
| Subcellular Localization | Cell membrane |
| Protein Family | G protein-coupled receptor |
Describe the protein structure including domains and post-translational modifications.
ADORA3 is an adenosine receptor that couples to Gi proteins, inhibiting adenylate cyclase. It modulates immune cell function and has anti-inflammatory properties.
ADORA3 activation reduces neuroinflammation in models of Alzheimer's and Parkinson's disease. It protects against ischemic injury.
ADORA3 agonists are being investigated for neuroinflammatory disorders. MRS5980 and other selective agonists show promise.
Adenosine A3 receptor (A3AR) activation plays a complex role in Parkinson's disease. Studies show that A3AR agonists may provide neuroprotection in PD through:
A3AR signaling affects amyloid-beta toxicity and tau phosphorylation, suggesting potential therapeutic applications in AD.
A3AR agonists are being investigated for neurodegenerative diseases due to their anti-inflammatory and neuroprotective effects.
Recent studies have demonstrated that A3AR activation can:
A3AR agonists have been in clinical trials for various conditions. Repurposing for neurodegenerative diseases is being explored.
A3AR signals through Gi/o proteins to:
A3AR is expressed in:
A3AR shows significant species differences in pharmacology, with human and rodent receptors having distinct agonist/antagonist profiles.
bfe67bb53c3c532ef4237fa3323691ae27404769